HYAL3 as a potential novel marker of BLCA patient prognosis
Abstract Background It has been previously demonstrated that hyaluronan (HA) potentially regulates the initiation and propagation of bladder cancer (BLCA). HYAL3 encodes hyaluronidase and is a potential therapeutic target for BLCA. We aimed to explore the role that HYAL3 plays in BLCA pathogenesis....
Main Authors: | Jun-peng Liu, Yu-tong Fang, Yi-fan Jiang, Hao Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Genomic Data |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12863-022-01070-w |
Similar Items
-
High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
by: Sergei Kusmartsev, et al.
Published: (2022-04-01) -
HYAL1 deficiency attenuates lipopolysaccharide-triggered renal injury and endothelial glycocalyx breakdown in septic AKI in mice
by: Hongxia Xing, et al.
Published: (2023-12-01) -
Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
by: He Zhang, et al.
Published: (2023-02-01) -
Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature
by: Chao Tang, et al.
Published: (2024-03-01) -
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients
by: Qun Wang, et al.
Published: (2021-02-01)